Jordi Riba Serrano PhD, a Spanish trailblazer in the resurgence of psychedelic science, passed away in August 2020 at the age of 51. His important contributions toward understanding the pharmacology of ayahuasca and other psychedelics will remain.
According to IIT, psychedelics cause concepts to form more links with each other than usual. This might explain several phenomena observed in psychedelic mind-states.
New research shows that ketamine reduces self-dislike, loosening the rigid prejudice toward oneself that can constitute depression.
Experiential avoidance is one transdiagnostic process that may be implicated in the therapeutic benefits of psychedelics.
While ketamine produces a whole symphony of effects in the brain, surprisingly, a localized neural oscillation in a lesser-known area of the brain is enough to cause feelings of dissociation.
Both have long-lasting positive effects on mood, social skills and neuroplasticity. Combining them may potentiate and prolong mutual therapeutic effects.
This study provides the first preliminary quantitative exploration of the psychological effects of psychedelics in individuals with a self-reported diagnosis of an eating disorder.
Harnessing the theoretical and technical synergy between Acceptance & Commitment Therapy (ACT) and Psilocybin-Assisted Psychotherapy (PcbAP)
A new clinical study reports that 20µg of LSD significantly reduces pain perception. This promising investigation builds on the little-known history of research into LSD as a potential analgesic.
"Now we know how psychedelic drugs work – finally! We might be able to switch some effects on while keeping others off."